COVID-19 (coronavirus) CEBT News
Please click here to view an important COVID-19 vaccine update from UMR. If you have Kaiser, please click here to view an update from them on the vaccine.
With the public health concern of COVID-19, the CEBT Board of Trustees has been in constant communication with each other regarding the virus and its potential impact on CEBT members. The Board is concerned about the health of all members and wants to remove barriers for testing for COVID-19, for both UMR and Kaiser medical plans. Effective February 4, 2020, the plan will waive cost sharing, including deductible, coinsurance and copays, for approved and authorized COVID-19 laboratory tests and test-related visits at a qualified practitioner's office, urgent care, emergency room, or telehealth/telemedicine including Teladoc visits, for covered persons.
Testing must be provided at approved locations in accordance with U.S. Centers for Disease Control and Prevention (CDC) guidelines.
If you think you may have been exposed, or certainly if you are experiencing symptoms, per the CDC it is recommended that you do not immediately visit your doctor’s office or a CEBT Health Center.
It is recommended that you call Teladoc (1-800-TELADOC), call your nearest CEBT Health Center, or call your doctor’s office and they will help you understand exposure and/or symptoms and guide you to the right place of care to get tested for COVID-19, if necessary.
This does not include mass/return-to-work screenings. Please refer to the plan amendment related to COVID-19 for additional detail.